In addition, CTLA-4 and PD-1 expression levels were low in brain regulatory T cells (Tregs) of glioma bearing mice [12], indicating that alternative (perhaps glioma-specific) immune checkpoints may play an essential role in immunosuppression of the glioma microenvironment. This evidence concerns the gene PDCD1 and central nervous system cancer.